Trials / Completed
CompletedNCT02196129
Immediate Pain Relieving Effects of Sinbaro-3 for Low Back Pain
Immediate Pain Relieving Effects of Sinbaro-3 Pharmaco-acupuncture in Low Back Pain Patients; A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Jaseng Hospital of Korean Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the immediate pain relieving effects of sinbaro-3 pharmaco-acupuncture in patients with low back pain admitted for inpatient care
Detailed description
60 patients with LBP with moderate to severe pain(NRS\>6) were randomly allocated to 2 groups. The experimental group was treated with sinbaro-3 pharmacoacupuncture and the control group was treated with Hwangryun pharmacoacupuncture. All administrations were limited to 1 session, and comparisons of measurements were made before and after treatment. Primary outcomes were measured using the VAS scale. Post-treatment follow-up will be performed to measure primary outcomes at 30 minutes, 2hours, 4hours, and 6 hours after treatment. Before and after each measurement, the patients are asked to stand up and rotate their torso. At termination of the study, satisfaction levels of the patient's current status will also be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sinbaro-3 | 1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain |
| DRUG | Hwangryun | 1cc administered to site of pain(ashi acupoints), once and once only before any other intervention/if pain in both low back and extermities, the site of most pain |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-10-01
- Completion
- 2014-11-01
- First posted
- 2014-07-21
- Last updated
- 2018-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02196129. Inclusion in this directory is not an endorsement.